menu

Loading...

SLQT Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

0.856

Open

0.840

VWAP

0.80

Vol

4.06M

Mkt Cap

138.56M

Low

0.750

Amount

3.24M

EV/EBITDA(TTM)

12.51

Total Shares

176.29M

EV

782.14M

EV/OCF(TTM)

64.82

P/S(TTM)

0.09

SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expenses, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy.

Show More

Events Timeline

(ET)

2026-01-15

07:10:00

SelectQuote Reaches New Agreement with Long-Time PBM Partner

2025-08-21 (ET)

2025-08-21

07:37:32

SelectQuote Announces Q4 EPS of 2 Cents, Below Consensus Estimate of 13 Cents

2025-07-02 (ET)

2025-07-02

16:16:03

SelectQuote vice chairman Tom Grant passes away

2025-05-12 (ET)

2025-05-12

07:36:04

SelectQuote sees FY25 revenue $1.5B-$1.575B, consensus $1.53B

2025-05-12

07:35:24

SelectQuote reports Q3 EPS 3c vs 5c last year

2025-05-09 (ET)

2025-05-09

08:04:34

SelectQuote responds to allegations in DOJ complaint

2025-05-01 (ET)

2025-05-01

14:51:08

SelectQuote down 40% after U.S. files False Claims Act complaint

News

seekingalpha

02-05seekingalpha

SelectQuote Reports Strong Q2 2026 Earnings Amid Guidance Cuts

seekingalpha

02-05seekingalpha

SelectQuote Q2 Earnings Exceed Expectations

seekingalpha

02-04seekingalpha

SelectQuote Scheduled to Announce Q2 Earnings on February 5th

Businesswire

01-12Businesswire

SelectQuote Secures $415 Million Credit Facility to Strengthen Financial Position

Globenewswire

2025-12-02Globenewswire

SelectQuote Faces Investigation Over Alleged Illegal Payments Exceeding $80 Million

Newsfilter

2025-11-24Newsfilter

SelectQuote Under Investigation for Alleged Illegal Payments Exceeding $80 Million

3 Analyst Rating

Wall Street analysts forecast SLQT stock price to rise

2 Buy

1 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

5.00

Averages

6.00

High

7.00

Current: 0.000

Low

5.00

Averages

6.00

High

7.00

Noble Capital

Outperform

downgrade

$7 -> $5

AI Analysis

2026-02-06

Reason

Noble Capital

Price Target

$7 -> $5

AI Analysis

2026-02-06

downgrade

Outperform

Reason

Noble Capital lowered the firm's price target on SelectQuote to $5 from $7 and keeps an Outperform rating on the shares to reflect updated forecasts and heightened near-term uncertainty following the company's fiscal Q2 report.

Craig-Hallum

Buy

downgrade

$4 -> $3

2026-02-06

Reason

Craig-Hallum

Price Target

$4 -> $3

2026-02-06

downgrade

Buy

Reason

Craig-Hallum lowered the firm's price target on SelectQuote to $3 from $4 and keeps a Buy rating on the shares. The firm notes the company reported Q2 results that were modestly ahead of estimates but lowered the full year guide.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for SLQT

Unlock Now

Valuation Metrics

The current forward P/E ratio for SelectQuote Inc (SLQT.N) is -6.04, compared to its 5-year average forward P/E of -10.05. For a more detailed relative valuation and DCF analysis to assess SelectQuote Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

-10.05

Current PE

-6.04

Overvalued PE

20.03

Undervalued PE

-40.13

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

1.33

Current EV/EBITDA

7.65

Overvalued EV/EBITDA

54.66

Undervalued EV/EBITDA

-52.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

N/A

5Y Average PS

0.72

Current PS

0.14

Overvalued PS

1.74

Undervalued PS

-0.30

Financials

AI Analysis

Annual

Quarterly

Whales Holding SLQT

Trading Trends

People Also Watch

Frequently Asked Questions

What is SelectQuote Inc (SLQT) stock price today?

The current price of SLQT is 0.786 USD — it has decreased -8.93

What is SelectQuote Inc (SLQT)'s business?

SelectQuote, Inc. provides a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. The Company has four core business lines: SelectQuote Senior, SelectQuote Healthcare Services, SelectQuote Life, and SelectQuote Auto and Home. SelectQuote’s Senior division sells Medicare Advantage, Medicare Supplement, Medicare Part D, and other ancillary senior health insurance related products. SelectQuote Healthcare Services comprises SelectRx Pharmacy, a specialized medication management pharmacy, and Population Health which proactively connects its members with healthcare services that fit each member's healthcare needs. SelectQuote’s Auto & Home division primarily sells non-commercial auto and home, property and casualty insurance products. SelectQuote’s Life division sells term life, final expenses, and other ancillary products. SelectRx is a Patient-Centered Pharmacy Home (PCPH) accredited pharmacy.

What is the price predicton of SLQT Stock?

Wall Street analysts forecast SLQT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SLQT is6.00 USD with a low forecast of 5.00 USD and a high forecast of 7.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is SelectQuote Inc (SLQT)'s revenue for the last quarter?

SelectQuote Inc revenue for the last quarter amounts to 537.10M USD, increased 11.65

What is SelectQuote Inc (SLQT)'s earnings per share (EPS) for the last quarter?

SelectQuote Inc. EPS for the last quarter amounts to 0.27 USD, decreased -10.00

How many employees does SelectQuote Inc (SLQT). have?

SelectQuote Inc (SLQT) has 1181 emplpoyees as of March 04 2026.

What is SelectQuote Inc (SLQT) market cap?

Today SLQT has the market capitalization of 138.56M USD.